The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ATHENE HOLDING LTD-CLASS A Common Stock G0684D107 41,423 1,215,467 SH   SOLE   1,215,467 0 0
MERSANA THERAPEUTICS INC Common Stock 72352L106 1,439 77,263 SH   SOLE   77,263 0 0
FUTU HOLDINGS LTD-ADR ADR 36118L106 1,695 59,239 SH   SOLE   59,239 0 0
RAPT THERAPEUTICS Common Stock 75382E109 542 16,830 SH   SOLE   16,830 0 0